The enrichment of KEGG pathways demonstrated the target genes are mainly related to the pathway in cancer, the Phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway, and the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor resistance pathway (Figure 4E). This evidence concerns the gene AKT1 and cancer.